David T. Grace
About David T. Grace
David T. Grace is the Vice President of Managed Markets Value & Access at Novartis, with over 15 years of experience in market access and managed markets roles. He has held various leadership positions at Bristol-Myers Squibb and inVentiv Health, and has a strong background in oncology and immuno-oncology market access strategies.
Company
David T. Grace is currently working at Novartis, where he holds the position of Vice President, Managed Markets Value & Access. He has held various roles within the company, including Executive Director, Access Lead for Inclisiran, and Executive Director, Access BU Lead for Ophthalmology and Retina products.
Title
David T. Grace holds the title of Vice President, Managed Markets Value & Access at Novartis. His role emphasizes the development and execution of market access strategies to ensure the company's pharmaceutical products are accessible to patients.
Education and Expertise
David T. Grace earned his MBA from New York University - Leonard N. Stern School of Business, focusing on Management. He also holds a Bachelor of Science in Pharmacy from Trinity College, Dublin. He has over 15 years of experience in market access and managed markets, with a deep understanding of the US healthcare market and payer landscape.
Background
David T. Grace has a diverse professional background, having worked at several prominent pharmaceutical companies. He started his career as a Managing Pharmacist at Unicare Pharmacy Group. He later held various roles at Bristol-Myers Squibb, including Director of Market Access Strategy and Market Access Strategy Lead for Oncology (Lung). Before joining Novartis, he was a Senior Consultant in Managed Markets at inVentiv Health.
Achievements
David T. Grace has a proven track record of leading market access strategies for high-impact pharmaceutical products. He played a significant role in the market access strategy for the launch of Inclisiran at Novartis and has developed strategies for lung cancer treatments and immuno-oncology at Bristol-Myers Squibb. His strong analytical skills and extensive experience in market access have been crucial in achieving organizational goals.